Board of Directors

Larry Stambaugh

Larry Stambaugh

Chairman of Board of Directors

Larry G Stambaugh serves as Molecular Assemblies’ Chairman of the Board. He is the founding principal at Apercu Partners, where he serves as an advisor to private, public and non-profit management and boards. Read More »

Michael Kamdar

Michael J. Kamdar

President, Chief Executive Officer and Board Member

Michael J. Kamdar joined Molecular Assemblies in 2016 as President, CEO and Board Member. An industry veteran with an expertise in business development and financing, Mr. Kamdar has accounted for deal transactions in excess of $1 billion and has raised more than $400 million from venture capital and the public capital markets. Read More »

William Efcavitch

J. William Efcavitch, Ph.D.

Chief Scientific Officer, Co-founder and Board Member

Bill Efcavitch co-founded Molecular Assemblies in 2013 and serves as Chief Scientific Officer. He was a founding member of Applied Biosystems, as the company’s ninth employee. Read More »

Joseph Smith

Board Member

Joseph Smith is currently CEO of Joseph Smith Ltd, a business and intellectual property consulting firm. Previously, he served as General Counsel and Executive Vice President, Corporate Development for Cepheid, a leading provider of molecular diagnostic testing products, where he was responsible for all legal and business development activities. Read More »

Curt Becker

Curt Becker

Chief Commercial Officer, Co-founder and Board Member

Curt Becker is a co-founder of Molecular Assemblies and serves as Chief Commercial Officer. He was a founding member of Applied Biosystems, where he was at the forefront of establishing the genomics tools business and the industrialization of genomics sciences. Read More »

Sean Freeman

Sean Freeman                                                    

Board Member

Mr. Freeman is currently Head of Strategy and Corporate Development at NuVasive, a leading medical device company, with responsibility for overseeing the company’s inorganic activity, including the management of its strategic venture portfolio. He has 20 years of international deal experience in mergers and acquisitions (M&A), licensing and strategic partnerships in the healthcare industry. Read More »